Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lukas Kenner

Showing results (241-250 of 267) with videos related to

Pageof 27
Sort By:
Molecular Systems Biology|April 24, 2020
STAT3-dependent analysis reveals PDK4 as independent predictor of recurrence in prostate cancerMonika Oberhuber, Matteo Pecoraro, Mate Rusz, et al.
Molecular Cancer|November 1, 2024
Cell-autonomous IL6ST activation suppresses prostate cancer development via STAT3/ARF/p53-driven senescence and confers an immune-active tumor microenvironmentChristina Sternberg, Martin Raigel, Tanja Limberger, et al.
Cancer Letters|December 3, 2014
Lobatin B inhibits NPM/ALK and NF-κB attenuating anaplastic-large-cell-lymphomagenesis and lymphendothelial tumour intravasationIzabella Kiss, Christine Unger, Chi Nguyen Huu, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|July 30, 2015
The germacranolide sesquiterpene lactone neurolenin B of the medicinal plant Neurolaena lobata (L.) R.Br. ex Cass inhibits NPM/ALK-driven cell expansion and NF-κB-driven tumour intravasationChristine Unger, Izabella Kiss, Andrea Vasas, et al.
The Journal of Experimental Medicine|February 24, 2018
ADAM17 is required for EGF-R-induced intestinal tumors via IL-6 trans-signalingStefanie Schmidt, Neele Schumacher, Jeanette Schwarz, et al.
Nature|June 18, 2025
Kupffer cell programming by maternal obesity triggers fatty liver diseaseHao Huang, Nora R Balzer, Lea Seep, et al.
Molecular Cancer|July 7, 2026
Correction: Cell‑autonomous IL6ST activation suppresses prostate cancer development via STAT3/ARF/p53‑driven senescence and confers an immune‑active tumor microenvironmentChristina Sternberg, Martin Raigel, Tanja Limberger, et al.
Cell Research|June 1, 2016
RANKL/RANK control Brca1 mutation- Verena Sigl, Kwadwo Owusu-Boaitey, Purna A Joshi, et al.
Leukemia|August 23, 2018
Dependency on the TYK2/STAT1/MCL1 axis in anaplastic large cell lymphomaNicole Prutsch, Elisabeth Gurnhofer, Tobias Suske, et al.
Leukemia|July 16, 2020
Correction: Dependency on the TYK2/STAT1/MCL1 axis in anaplastic large cell lymphomaNicole Prutsch, Elisabeth Gurnhofer, Tobias Suske, et al.
Pageof 27

Showing results (241-250 of 267) with videos related to

Sort By:
Pageof 27
Molecular Systems Biology|April 24, 2020
STAT3-dependent analysis reveals PDK4 as independent predictor of recurrence in prostate cancerMonika Oberhuber, Matteo Pecoraro, Mate Rusz, et al.
Molecular Cancer|November 1, 2024
Cell-autonomous IL6ST activation suppresses prostate cancer development via STAT3/ARF/p53-driven senescence and confers an immune-active tumor microenvironmentChristina Sternberg, Martin Raigel, Tanja Limberger, et al.
Cancer Letters|December 3, 2014
Lobatin B inhibits NPM/ALK and NF-κB attenuating anaplastic-large-cell-lymphomagenesis and lymphendothelial tumour intravasationIzabella Kiss, Christine Unger, Chi Nguyen Huu, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|July 30, 2015
The germacranolide sesquiterpene lactone neurolenin B of the medicinal plant Neurolaena lobata (L.) R.Br. ex Cass inhibits NPM/ALK-driven cell expansion and NF-κB-driven tumour intravasationChristine Unger, Izabella Kiss, Andrea Vasas, et al.
The Journal of Experimental Medicine|February 24, 2018
ADAM17 is required for EGF-R-induced intestinal tumors via IL-6 trans-signalingStefanie Schmidt, Neele Schumacher, Jeanette Schwarz, et al.
Nature|June 18, 2025
Kupffer cell programming by maternal obesity triggers fatty liver diseaseHao Huang, Nora R Balzer, Lea Seep, et al.
Molecular Cancer|July 7, 2026
Correction: Cell‑autonomous IL6ST activation suppresses prostate cancer development via STAT3/ARF/p53‑driven senescence and confers an immune‑active tumor microenvironmentChristina Sternberg, Martin Raigel, Tanja Limberger, et al.
Cell Research|June 1, 2016
RANKL/RANK control Brca1 mutation- Verena Sigl, Kwadwo Owusu-Boaitey, Purna A Joshi, et al.
Leukemia|August 23, 2018
Dependency on the TYK2/STAT1/MCL1 axis in anaplastic large cell lymphomaNicole Prutsch, Elisabeth Gurnhofer, Tobias Suske, et al.
Leukemia|July 16, 2020
Correction: Dependency on the TYK2/STAT1/MCL1 axis in anaplastic large cell lymphomaNicole Prutsch, Elisabeth Gurnhofer, Tobias Suske, et al.
Pageof 27